http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2237040-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38d7837b090198da43ab82b667b3ec0d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-8117
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6857
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
filingDate 2002-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3aae407edd386f545d80857efb50fdc
publicationDate 2010-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2237040-A2
titleOfInvention Determination of level of immunoglobulin fragmentation or modification and use of a trypsin inhibitor for preventing the same
abstract The invention provides a trypsin inhibitor for use in a method of treating or preventing a disorder associated with elevated trypsin activity which is correlated with IgG fragmentation or modification. The invention also provides a method for determining the risk of an individual of suffering from inflammation, opportunistic infection or disruption of immunoglobulin metabolism, comprising (a) determining the level of fragmentation or modification of Fc function of immunoglobulins in a sample taken from the individual and (b) determining thereby the risk of inflammation, impaired immune response or opportunistic infection.
priorityDate 2001-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136069385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129177339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226548214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4686862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129763036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77473

Total number of triples: 37.